Related references
Note: Only part of the references are listed.Wound healing grafts: Omega-3 fatty acid lipid content differentiates the lipid profiles of acellular Atlantic cod skin from traditional dermal substitutes
Aristotelis Kotronoulas et al.
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2020)
Alzheimer Disease Pathogenesis: Insights From Molecular and Cellular Biology Studies of Oligomeric Aβ and Tau Species
Xu-Qiao Chen et al.
FRONTIERS IN NEUROSCIENCE (2019)
Astrocyte Biomarkers in Alzheimer's Disease
Stephen F. Carter et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders
Bob Olsson et al.
JAMA NEUROLOGY (2019)
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Piotr Lewczuk et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Lipid Biomarkers in Alzheimer's Disease
Amira Zarrouk et al.
CURRENT ALZHEIMER RESEARCH (2018)
YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer's disease and other tauopathies
Marta Querol-Vilaseca et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium
Ian G. McKeith et al.
NEUROLOGY (2017)
Targeting Neuroinflammation to Treat Alzheimer's Disease
A. Ardura-Fabregat et al.
CNS DRUGS (2017)
Neuroinflammation in Alzheimer's disease: Current evidence and future directions
Valeria Calsolaro et al.
ALZHEIMERS & DEMENTIA (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease
Kelsey E. Melah et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate
Antonio Gomez-Munoz et al.
PROGRESS IN LIPID RESEARCH (2016)
The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
Urmi Sengupta et al.
EBIOMEDICINE (2016)
MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis
Hiroshi Tsugawa et al.
NATURE METHODS (2015)
Immune attack: the role of inflammation in Alzheimer disease
Frank L. Heppner et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease
Daniel Alcolea et al.
NEUROBIOLOGY OF AGING (2015)
Ceramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ Accumulation
Maja Jazvinscak Jembrek et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
Sphingolipid Metabolism Correlates with Cerebrospinal Fluid Beta Amyloid Levels in Alzheimer's Disease
Alfred N. Fonteh et al.
PLOS ONE (2015)
Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker
Zhihui Yang et al.
TRENDS IN NEUROSCIENCES (2015)
A Genome-wide Gene-Expression Analysis and Database in Transgenic Mice during Development of Amyloid or Tau Pathology
Mar Matarin et al.
CELL REPORTS (2015)
Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes
Luca Steardo et al.
FRONTIERS IN NEUROSCIENCE (2015)
The cerebrospinal fluid Alzheimer profile: Easily said, but what does it mean?
Flora H. Duits et al.
ALZHEIMERS & DEMENTIA (2014)
Relationship Between β-Secretase, Inflammation and Core Cerebrospinal Fluid Biomarkers for Alzheimer's Disease
Daniel Alcolea et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Cerebrospinal Fluid Level of YKL-40 Protein in Preclinical and Prodromal Alzheimer's Disease
Anna Antonell et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease
Michelle M. Mielke et al.
NEUROBIOLOGY OF AGING (2014)
Meta-review of CSF core biomarkers in Alzheimer's disease: the state-of-the-art after the new revised diagnostic criteria
Daniel Ferreira et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Astrocytes: Conductors of the Alzheimer disease neuroinflammatory symphony
Rodrigo Medeiros et al.
EXPERIMENTAL NEUROLOGY (2013)
Cross-talk of membrane lipids and Alzheimer-related proteins
Jochen Walter et al.
MOLECULAR NEURODEGENERATION (2013)
LipidBlast in silico tandem mass spectrometry database for lipid identification
Tobias Kind et al.
NATURE METHODS (2013)
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia-Chan Liu et al.
NATURE REVIEWS NEUROLOGY (2013)
Fatting the brain: a brief of recent research
Ghulam Hussain et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Astrocyte and Macrophage Regulation of YKL-40 Expression and Cellular Response in Neuroinflammation
Dafna Bonneh-Barkay et al.
BRAIN PATHOLOGY (2012)
Increased Ceramide in Brains with Alzheimer's and Other Neurodegenerative Diseases
Valery Filippov et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
Serum Lipidomics Profiling Using LC-MS and High-Energy Collisional Dissociation Fragmentation: Focus on Triglyceride Detection and Characterization
Susan S. Bird et al.
ANALYTICAL CHEMISTRY (2011)
Diet-induced elevations in serum cholesterol are associated with alterations in hippocampal lipid metabolism and increased oxidative stress
Alexis M. Stranahan et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis
Norman J. Haughey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
Rebecca Craig-Schapiro et al.
BIOLOGICAL PSYCHIATRY (2010)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
Lipidomics: coming to grips with lipid diversity
Andrej Shevchenko et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Deregulation of sphingolipid metabolism in Alzheimer's disease
Xingxuan He et al.
NEUROBIOLOGY OF AGING (2010)
Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease
Lesley Jones et al.
PLOS ONE (2010)
S100B's double life: Intracellular regulator and extracellular signal
Rosario Donato et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling
Archana Mukhopadhyay et al.
FASEB JOURNAL (2009)
Validity of Cerebrospinal Fluid Biomarkers as Endpoints in Early-Phase Clinical Trials for Alzheimer's Disease
Bin Zhou et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Multimodal techniques for diagnosis and prognosis of Alzheimer's disease
Richard J. Perrin et al.
NATURE (2009)
Principles of bioactive lipid signalling: lessons from sphingolipids
Yusuf A. Hannun et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Membrane lipids: where they are and how they behave
Gerrit van Meer et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Alzheimer's disease: the lipid connection
Tobias Hartmann et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: A shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease?
Pavel Katsel et al.
NEUROCHEMICAL RESEARCH (2007)
Lipids as modulators of proteolytic activity of BACE - Involvement of cholesterol, glycosphingolipids, and anionic phospholipids in vitro
L Kalvodova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Regulation of cholesterol and sphingomyelin metabolism by amyloid-β and presenilin
MOW Grimm et al.
NATURE CELL BIOLOGY (2005)
Astroglial expression of ceramide in Alzheimer's disease brains: A role during neuronal apoptosis
H Satoi et al.
NEUROSCIENCE (2005)
Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease
RG Cutler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Amyloid-β peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway
JT Lee et al.
JOURNAL OF CELL BIOLOGY (2004)
Mild cognitive impairment -: beyond controversies, towards a consensus:: report of the International Working Group on Mild Cognitive Impairment
B Winblad et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Transcriptional regulation of CHI3L1, a gene for late stages of macrophage differentiation
M Rehli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
CD36 mediates the innate host response to β-amyloid
JB El Khoury et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Ceramide stabilizes β-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid β-peptide biogenesis (Withdrawn Publication. See vol. 298, 2022) (Withdrawn Publication. See vol. 298, 2022)
L Puglielli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Immune reactive cells in senile plaques and cognitive decline in Alzheimer's disease
AK Vehmas et al.
NEUROBIOLOGY OF AGING (2003)
Sphingosine in apoptosis signaling
O Cuvillier
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2002)
Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis
XL Han et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation
HJ Huttunen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
